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Abstract
S-nitrosothiols have been implicated in the etiology of various pulmonary diseases. Many of these diseases display gender
preferences in presentation or altered severity that occurs with puberty, the mechanism by which is unknown. Estrogen has
been shown to influence the expression and activity of endothelial nitric oxide synthase (eNOS) which is associated with
increased S-nitrosothiol production. The effects of gender hormones on the expression and activity of the de-nitrosylating
enzyme S-nitrosoglutathione reductase (GSNO-R) are undefined. This report evaluates the effects of gender hormones on
the activity and expression of GSNO-R and its relationship to N-acetyl cysteine (NAC)-induced pulmonary hypertension (PH).
GSNO-R activity was elevated in lung homogenates from female compared to male mice. Increased activity was not due to
changes in GSNO-R expression, but correlated with GSNO-R S-nitrosylation: females were greater than males. The ability of
GSNO-R to be activated by S-nitrosylation was confirmed by: 1) the ability of S-nitrosoglutathione (GSNO) to increase the
activity of GSNO-R in murine pulmonary endothelial cells and 2) reduced activity of GSNO-R in lung homogenates from
eNOS
2/2 mice. Gender differences in GSNO-R activity appear to explain the difference in the ability of NAC to induce PH:
female and castrated male animals are protected from NAC-induced PH. Castration results in elevated GSNO-R activity that
is similar to that seen in female animals. The data suggest that GSNO-R activity is modulated by both estrogens and
androgens in conjunction with hormonal regulation of eNOS to maintain S-nitrosothiol homeostasis. Moreover, disruption
of this eNOS-GSNO-R axis contributes to the development of PH.
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Introduction
S-nitrosylation, a redox-based modification of a cysteine thiol by
nitric oxide, is a post translational modification that can alter a
protein’s function. Mechanisms that control the addition and/or
removal of the NO group from cysteine thiols are essential in
determining the net effect of this modification. Formation of
endogenous S-nitrosothiols can be mediated through: 1) the activity
of any one of the nitric oxide synthase (NOS) isoforms, 2) oxidative
reactions generating nitrosative species (for example, Fe
+3NO,
N2O3,) or 3) transnitrosative reactions (NO
+-transfer) [1–3]. The
production of S-nitrosothiols is opposed by mechanisms mediat-
ing de-nitrosylation which can: 1) occur non-enzymatically via
homolytic or heterolytic cleavage, 2) be catalyzed by transition
metal ions and reactive oxygen species, or 3) occur through
enzymatic degradation [1,4]. One specific enzyme that regulat-
es S-nitrosothiol catabolism is S-nitrosoglutathione reductase
(GSNO-R), a ubiquitously expressed NADH-dependent enzyme
[2]. GSNO-R is responsible for the breakdown of S-nitrosoglu-
tathione (GSNO) to oxidized glutathione and ammonia [5,6].
Although the primary substrate for GSNO-R is GSNO [5,6], the
levelsof other S-nitrosylated-proteins areaffected indirectly through
altered transnitrosation equilibria with GSNO.
S-nitrosothiols have been implicated in pulmonary diseases such
as cystic fibrosis [3,7–9], pulmonary hypertension [3,7,10,11] and
asthma [3,7,12,13]. All of these pulmonary diseases display distinct
gender preferences in presentation or a change in disease severity
that occurs at puberty, the cause of which is unknown [14–17].
Gender differences in the activity and/or expression of GSNO-R
have been suggested. Gastric activity of GSNO-R may be a
component of the enhanced vulnerability of women to develop
alcohol–related diseases [18]. Likewise, gender differences seen in
the lipopolysaccharide (LPS) model of septic shock are eliminated
in GSNO-R knockout mice [6]. To date, the influence of de-
nitrosylation on the gender predilection of these lung diseases has
not been addressed. The current studies evaluate the relationship
between gender and the activity and/or expression of GSNO-R in
the lung. The data demonstrate that GSNO-R activity is elevated
in the female mouse lung when compared to the male. This
increased activity does not reflect differences in GSNO-R protein
expression, but rather, reflects differences both in endothelial nitric
oxide synthase (eNOS)-dependent GSNO-R S-nitrosylation and
androgen exposure. Indeed, mice deficient in eNOS have reduced
GSNO-R activity, and S-nitrosylation increases GSNO-R activity,
suggesting that estrogen-dependent increases in eNOS lead to
increased GSNO-R activity in the female lung, protecting against
excessive S-nitrosylation. Lastly, this gender discordance in the
eNOS/GSNO-R axis is relevant to pulmonary biology. Female
mice are protected from the physiological effects mediated by the
conversion of N-acetyl cysteine (NAC) to S-nitroso-N-acetyl
cysteine (SNOAC) in vivo, despite increased eNOS expression.
However, they develop hypoxia-mimetic pulmonary hypertension
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e14007(PH) in response to chronic SNOAC exposure like their male
littermates. This observation may have implications for human
disease. For example, increased eNOS expression in females could
predispose them to PH if the counter-regulatory GSNO-R
response is abnormal.
Results
GSNO-R activity, not protein expression, is greater in lung
homogenates of female than male mice
Initial studies evaluated the activity and expression of GSNO-R
in lung homogenates in male and female mice. GSNO-R activity
was evaluated using liquid chromatography/mass spectroscopy
(LC/MS). GSNO-R activity measured by LC/MS was signifi-
cantly higher in adult (10–12 w) female animals compared to their
corresponding adult male counterparts (Figure 1A). Similar gender
specific differences (2–3 fold) were detected when GSNO-R
activity was measured by GSNO-dependent NADH consumption
or modified Saville Assay (Tables 1,2,3) In contrast, no significant
differences in GSNO-R activity were seen in the lungs of young
(4 w) male and female animals (Figure 1B). To determine if this
gender difference was specific for the lung, GSNO-R activity was
measured in the liver and the kidney. Unlike the lung, no gender
specific differences in GSNO-R activity were seen in either tissue
(Tables 1 and 2). To determine if the differences in GSNO-R
activity in the adult murine lung were due to changes in protein
expression, Western blot analysis was performed (Figure 1C). No
significant differences in GSNO-R protein expression were seen in
the lung homogenates of adult male and female animals.
GSNO-R S-nitrosylation is greater in female than male
mice
The detected difference in GSNO-R activity present in the lung
homogenates of male and female animals could be explained by
differences in S-nitrosylation. To examine if GSNO-R is an S-
nitrosylated protein, lung homogenates obtained from male and
female animals were subjected to biotin switch followed by
Western blot analysis (Figure 1D). GSNO-R was found to be S-
nitrosylated in both male and female lung homogenates. The level
of S-nitrosylation was greater in lung homogenates of female mice
as compared to lung homogenates from male animals. S-
nitrosylation was confirmed by the ability of mercuric chloride
to significantly reduce the appearance of S-nitrosylated GSNO-R.
S-nitrosoglutathione activates GSNO-R
Post-translational modifications by S-nitrosylation often results
in a change in a protein’s activity. Previous data demonstrate lung
homogenates obtained from female animals have greater GSNO-
R activity and elevated GSNO-R S-nitrosylation compared to
male animals, suggesting that S-nitrosylation and activity are
related. To define the impact of S-nitrosylation on the activity of
GSNO-R, murine pulmonary endothelial cells were treated with
and without 10 mM GSNO for 5 min. GSNO-R activity was
measured in cell homogenates obtained from the untreated and
treated cells. Treatment of murine lung endothelial cells with
GSNO resulted in a significant increase in GSNO-R activity
(Figure 2A). To determine if GSNO-R can be directly S-
nitrosylated, cell lysates from murine pulmonary endothelial cells
were treated with or without 5 mM L-SNO-cysteine (L-SNO-Cys)
for 5 minutes and GSNO-R activity measured using alterations in
NADH consumption. L-SNO-Cys was found to significantly
increase NADH consumption approximately 2 fold (Figure 2B).
This increase in NADH consumption with L-SNO-Cys was
independent of gender.
Endothelial nitric oxide synthase increases GSNO-R
Activity
eNOS is the prominent isoform present in the pulmonary
vascular endothelium. Estrogen increases the expression and
Figure 1. GSNO-R activity and S-nitrosylation is elevated in the
female mouse lung. (A) GSNO-R activity was measured in lung
homogenates from male and female C57Bl6/129SvEv mice using LC/MS.
GSNO-R activity is expressed as the amount of GSNO catabolized after
5 min. Activity present in female mouse lung homogenates was
approximately two times that seen in the males (n=20, p,0.003).
(B) GSNO-R activity was measured by LC/MS in lung homogenates from
young (4 w) C57Bl6/129SvEv sexually immature male and female mice.
Gender differences in GSNO-R activity were not seen in the young animals
(n=5). (C) GSNO-R protein expression was determined in adult C57Bl6/
129SvEv male and female lung homogenates. Protein expression was not
significantly different between genders. (D) Lung homogenates from
C57Bl6/129SvEv male and female mice were subjected to biotin switch to
determine if GSNO-R was S-nitrosylated in vivo. Lung homogenates from
both male and female animals demonstrate the presence of GSNO-R
S-nitrosylation. However, the extent of S-nitrosylation was greater in the
female animals. Incubation of the lung homogenates with mercuric
chloride reduced the abundance of S-nitrosylated GSNO-R.
doi:10.1371/journal.pone.0014007.g001
Table 1. GSNO-R Activity determined by GSNO-dependent
NADH Consumption is greater in lung homogenates obtained
from female mice.
GSNO-dependent NADH Consumption (mM NADH/min/
mg protein)
Male Female
Female: Male
Ratio
Lung 5.51+/22.9 10.58+/23.6 1.92
Liver 28.1+/23.77 19.46+/25.75 0.70
Kidney 39.96+/28.68 34.32+/29.11 0.85
GSNO-R activity was measured in lung, liver, and kidney homogenates obtained
from adult (10–12 w) male and female mice using a GSNO-dependent NADH
Consumption assay. NADH consumption was evaluated in homogenates
(0.3 mg) in the absence or presence of 100 mM GSNO. Gender specific
differences were seen in the lung homogenates (n=4). No gender specific
differences were seen with either the liver or the kidney homogenates (n=2–4).
doi:10.1371/journal.pone.0014007.t001
Gender and GSNO-R Activity
PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e14007activity of eNOS [19,20]. Consistent with this observation, lung
homogenates from female mice contained greater eNOS protein
expression when compared to lung homogenates from male mice
(Figure 3A). Increases in NOS activity are associated with
increased formation of S-nitrosothiols. To determine if the
increase in GSNO-R activity in the lungs of female animals is
due to estrogen-induced increases in eNOS activity, murine
pulmonary endothelial cells isolated from female mice were
treated with 10 nM estrogen in the absence or presence of L-
NAME. Estrogen increased the level of S-nitrosylated GSNO-R
compared to control cells (Figure 3B). This increase was abrogated
in the presence of L-NAME. To further confirm the effects of
eNOS on the activity of GSNO-R, GSNO-R activity was
examined in lung homogenates of eNOS deficient (eNOS
2/2)
mice using the modified Saville Assay (Figure 4A). Consistent with
a role for eNOS in regulating the activity of GSNO-R, GSNO-R
activity was found to be reduced by approximately 50% in
eNOS
2/2 animals compared to wild type control animals. The
reduction in GSNO-R activity was not mediated by a decrease in
GSNO-R expression (Figure 4B).
Table 2. GSNO-R activity measured by modified Saville Assay
is greater in lung homogenates obtained from female mice.
NADH-Dependent GSNO-R Activity (mM GSNO/min/mg
protein)
Male Female
Female: Male
Ratio
Lung 2.56+/20.20 5.32+/21.06 2.07
Liver 6.24+/21.96 6.14+/20.25 0.98
Kidney 5.68+/20.69 6.06+/21.1 1.10
GSNO-R activity was determined in homogenates from the lung, liver and
kidney of adult male and female mice. GSNO-R activity was measured in
homogenates (250 mg) in the presence of 100 mM GSNO in the presence or
absence of NADH at 37uC for 5 min. GSNO-R activity was significantly higher in
lung homogenates obtained from female mice compared to male mice (n=4).
No gender specific differences were seen in either the liver or kidney
homogenates (n=2–4).
doi:10.1371/journal.pone.0014007.t002
Table 3. Comparison of Methods used to Measure NADH-
Dependent GSNO-R Activity.
Gender
[GSNO]
mM
GSNO-R activity
mM/min/mg
protein
Protein pre-
cipitation
Female:Ma-
le ratio
Female 28 5.01+/21.51 N
Male 28 2.37+/20.35 N 2.11
Female 28 3.94+/21.52 Y
Male 28 1.16+/20.33 Y 3.40
Female 100 8.41+/22.69 N
Male 100 3.06+/20.52 N 2.75
Female 100 5.32+/21.06 Y
Male 100 2.56+/20.20 Y 2.07
Lungs were harvested from adult (10–12 w) C57Bl6/129SeEv mice. Lung
homogenates were subjected to NADH-dependent GSNO-R activity. The assay
was performed as described in Methods. The effect of altering the
concentration of GSNO in the assay and the precipitation of protein prior to
measurement were compared in the same samples (n=4). Note that higher
activity was obtained in the absence of protein precipitation for both GSNO
concentrations. Highest GSNO-R activity was obtained in the presence of
100 mM GSNO. GSNO-R activity was found to be 2–3 fold higher in the lung
homogenates from female animals regardless of the method used to measure
activity.
doi:10.1371/journal.pone.0014007.t003
Figure 2. S-nitrosoglutatione activates GSNO-R. (A) Primary
mouse lung endothelial cells were treated with 10 mM GSNO for
5 min and the activity of GSNO-R determined using a modified Saville
Assay using 28 mM GSNO. GSNO-R activity was significantly increased
after treatment of GSNO. (n=3, p,0.011). (B) Cell lysates obtained from
mouse lung endothelial cells were treated with or without 5 mM L-SNO-
cysteine for 5 min. GSNO-R activity was measured by L-SNO-cysteine
dependent NADH consumption. L-SNO-Cysteine resulted in a 2 fold
increase in NADH consumption (n=4, p,0.011).
doi:10.1371/journal.pone.0014007.g002
Figure 3. Estrogen Activation of GSNO-R is eNOS dependent.
(A) Abundance of eNOS present in lung homogenates from male and
female C57Bl6/129SvEv mice was determined by Western blot analysis
using antibodies directed against eNOS and b-actin. eNOS protein levels
were greater in lung homogenates of female animals. (B) Mouse lung
endothelial cells isolated from female mouse lungs were treated with or
without 10 mM estrogen in the presence or absence of 100 mM L-NAME
for 4 h. Estrogen resulted in an increase in GSNO-R S-nitrosylation. The
increased in GSNO-R S-nitrosylation was abrogated by pretreatment
with L-NAME.
doi:10.1371/journal.pone.0014007.g003
Gender and GSNO-R Activity
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ventricular weight and right ventricular pressure with
NAC
NAC was found in increase right ventricular pressure and right
ventricular weight in C57BL6/129SEV male mice in a manner
that was indistinguishable from that induced by hypoxia [11].
Published data indicate that female gender is less susceptible to
hypoxia induced PH (21–23). To determine if the female gender is
less susceptible to NAC-induced PH, C57BL6/129SvEv mice
were subjected to normoxia, 10 mg/ml NAC, 1 mg/ml SNOAC,
or hypoxia for a period of three weeks [11]. In contrast to the male
animals [11], the female animals responded with increases in right
heart weight and right ventricular pressure only after treatment
with SNOAC and hypoxia (Figure 5A, B).
Serum SNOAC levels are greater in male mice
NAC is S-nitrosylated forming SNOAC in the plasma [11]. To
examine the relative levels of SNOAC present in the plasma in
male and female animals, blood was harvested from the right
ventricle of NAC-treated mice and SNOAC levels determined by
mass spectroscopy. The level of SNOAC found in the plasma of
NAC treated female animals was significantly less than SNOAC
levels found in the plasma obtained from NAC-treated male
animals (Figure 6). None the less, exogenous administration of
SNOAC still resulted in increases in right ventricular pressure and
right ventricular weight characteristic of PH (Figure 5) In contrast,
analysis of the total amount of endogenously produced S-
nitrosothiols in whole blood taken from the left ventricle of
untreated male and female mice demonstrate no significant
differences in the levels of S-nitrosothiols (Table 4).
Castration increases GSNO-R activity and protects males
from NAC-induced pathology
Male animals develop PH when exposed to chronic systemic
administration of NAC [11]. To determine if sex hormones
influence the ability of NAC to induce changes in right ventricular
weight and right ventricular pressure in mice, the pulmonary
effects of NAC were examined in castrated mice (Figure 7A, B).
Analysis of right ventricular weight and right ventricular pressure
in the castrated animals show no significant difference between in
gonad intact and castrated animals under untreated conditions.
However, castrated animals were protected from the increases in
right ventricular weight and right ventricular pressure in response
to NAC. Castration was accompanied by an increase in GSNO-R
activity compared to the gonad intact animals as measured by
LC/MS (Figure 8A). The increase in GSNO-R activity was not
mediated by increases in GSNO-R protein expression (Figure 8B),
but to changes in GSNO-R S-nitrosylation (Figure 8C). Moreover,
GSNO-R activity in the castrated animals was comparable to that
seen in female animals. It should be noted that eNOS
phosphorylation at serine 1177 in castrated animals was elevated
compared to gonad intact animals (Figure 8B). To further evaluate
the role of androgens in the activation of GSNO-R, eNOS
2/2
animals were castrated and the activity of GSNO-R was evaluated
using a modified Saville Assay. Surprisingly, GSNO-R activity in
eNOS
2/2 castrated animals was significantly increased compared
to eNOS
2/2 gonad intact animals (Figure 9) suggesting the
presence of an eNOS-independent androgen mediated effect on
GSNO-R activity.
Discussion
Cysteine S-nitrosylation/de-nitrosylation is a regulated process
in normal physiology which has parallels to the protein kinase/
phosphatase system [1]. All NOS isoforms as well as other proteins
have been shown to cause formation of S-nitrosothiol bonds on
specific cysteine residues in co-localized proteins and/or cellular
peptides. Likewise, specific enzymes and other proteins are
responsible for de-nitrosylating these cysteine residues, particularly
downstream of transnitrosation reactions between S-nitrosylated
proteins and glutathione. One de-nitrosylating enzyme is S-
nitrosoglutathione reductase (GSNO-R), a ubiquitously expressed
NADH-dependent enzyme. GSNO-R has been shown to be
necessary for a variety of effects ranging from the nitrosylation of
G-protein coupled receptor kinases to cellular protection from
pathological nitrosative stress [1].GSNO-R activity in this
manuscript was measured by LC/MS, GSNO-dependent NADH
consumption, and modified Saville Assay (Tables 1,2,3). Regard-
less of the method used to measure GSNO-R activity, GSNO-R
activity was found to be approximately 2–3 fold higher in the lung
homogenates obtained from female animals. In contrast, lung
homogenates obtained from sexually immature mice did not
demonstrate any gender specific differences in GSNO-R activity.
Moreover, the gender-dependent effects on GSNO-R activity
appear to be specific for the lung as GSNO-R activity in kidney
and the liver homogenates were not seen. The data, taken
together, strongly suggests gender, most likely through the
influence gonadal steroids, influences the activity of GSNO-R in
the lung.
High-dose, long term systemic treatment with NAC causes PH
in male mice by conversion to SNOAC resulting in the
upregulation of hypoxia regulated genes [11]. This effect is
eNOS-dependent as eNOS
2/2 mice are completely protected
[11]. In this report, we demonstrate: 1) NAC treatment results in
lower plasma SNOAC levels in female mice than in male mice,
Figure 4. eNOS is required for GSNO-R activity. (A) GSNO-R
activity was measured in the lung homogenates obtained from eNOS
2/2
and wild type (C57Bl6) mice using a modified Saville Assay using 28 mM
GSNO withnoprotein precipitation. GSNO-Ractivitywasreducedby50%
intheeNOS
2/2 lunghomogenatecomparedtothat seeninthewildtype
mice (n=5–6, p,0.002). (B) Western blot analysis of GSNO-R protein
present in wild type (C57Bl6) and eNOS
2/2 mouse lungs. No significant
differences were detected in GSNO-R protein levels (n=3).
doi:10.1371/journal.pone.0014007.g004
Gender and GSNO-R Activity
PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e14007despite increased eNOS expression and 2) female mice exposed to
long term NAC treatment do not develop PH in contrast to male
mice. We hypothesize that in vivo, females might be protected
against eNOS–dependent nitrosative stress through the actions of
GSNO-R. This GSNO-R based protection can be overwhelmed
by chronic high dose systemic SNOAC treatment or by chronic
hypoxia.
Female rats [21,22] and swine [23] have been shown to develop
less severe PAH in response to chronic hypoxia compared to
males. Sex hormones may be involved in mediating this gender
dependent difference. Estrogen receptors are present in the rat
[24] and human lung [25]. Female animals produce more estrogen
which is known to enhance the vascular expression and activity of
eNOS [22,25]. This increase in eNOS protein/activity levels is
thought to be responsible for the protective effects on the
vasculature. In support of this concept, estrogens have been
shown to attenuate the severity of PH in rats [22], although the
mechanism by which this occurs does not appear to be associated
with alterations in eNOS expression [22]. Theoretically, increased
eNOS levels produce an increase in S-nitrosylated proteins. Thus,
GSNO-R might protect against nitrosative stress, which would be
anticipated to be greater in female mice than in males because of
the estrogen-mediated increase in eNOS activity. In this report,
GSNO-R activity is, indeed, higher in the female mouse lung
when compared to the male. Surprisingly, this difference was not
driven by a difference in protein expression, but rather by a
difference in activity.
Analysis of S-nitrosothiol levels in the serum of untreated
normal male and female mice indicate no significant differences in
S-nitrosothiol levels, suggesting that the formation and catabolism
of S-nitrosothiols is balanced in healthy untreated animals.
Because eNOS activity is elevated in the female mouse lung, it is
possible that GSNO-R opposes protein S-nitrosylation by eNOS
through its de-nitrosylating activity. Thus, the increased eNOS
activity present in the female mouse lung might lead to the
increased GSNO-R activity as a counter-regulatory mechanism to
minimize nitrosative stress. Indeed, in vitro treatment of
endothelial cells with GSNO increases GSNO-R activity through
S-nitrosylation. This appears to be confirmed in vivo as eNOS
2/2
mice (reduced S-nitrosothiol formation) have decreased GSNO-R
activity which is not due to decreased expression. Moreover, in
other maladies, there is evidence for gender discordance in
GSNO-R expression and/or activity. For instance, gastric activity
of GSNO-R may be a component of the enhanced vulnerability of
women to develop alcohol–related diseases [8]. Likewise, gender
differences seen in the LPS model of septic shock are eliminated in
GSNO-R knockout mice [4]. However, the gender dependent
differences in GSNO-R activity in the pulmonary vasculature and
the influence this may have on the gender predilection of
pulmonary diseases, such as PH have not been examined.
Figure 5. Female C57BL6/129SvEv mice do not develop PH with chronic, systemic administration of N-acetyl cysteine. C57Bl/129SvEv
mice were untreated (N) or treated with 10 mg/ml NAC (NAC), 52 mM SNOAC (SNOAC) or hypoxia (H) for a period of 3 weeks. (A) Right ventricular
pressure (RVP) and (B) right heart weight (expressed as right ventricular weight/left ventricular weight + septum weight (RV/LV+S) were determined.
Female mice responded to only to SNOAC and hypoxia. * (n=19–25,p ,0.05).
doi:10.1371/journal.pone.0014007.g005
Gender and GSNO-R Activity
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regulating the activity of GSNO-R. Specifically, castration increases
GSNO-R activity to a level similar to that seen in female mice. This
increase does not appear to be dueto increasesin protein expression
but again reflects increases in GSNO-R S-nitrosylation. Moreover,
the resultingincrease in GSNO-R activity correlates withprotection
from NAC-induced PH. The mechanism by which androgens
activate GSNO-R is not yet known. The data indicate, on one level,
castration increases the expression and activity of eNOS, consistent
with the observation that eNOS
2/2 mice have reduced GSNO-R
activity. It also suggests that androgens decrease the expression and
activity of eNOS within the pulmonary vasculature. However, the
effects ofandrogens on eNOS expressionand activity areincontrast
to published data. For instance, in the aorta, androgens have been
reported to activate eNOS through a non-genomic pathway
mediated bycSrc,PI3K andAkt[26,27]. Moreover, maleandrogen
receptor knockout mice show decreased aortic eNOS expression
and phosphorylatedeNOScompared to wild type mice[28]. Lastly,
neither androgen receptors nor nitric oxide are involved in the
vasodilatory actions in the pulmonary vasculature in response to
acute administration of testosterone, a major androgen produced in
the testes [29]. The reasons for these discrepancies are unclear, but
may be due to the vascular bed studied, or differences mediated by
chronic versus acute effects of androgens. On a second level, studies
examining the activity of GSNO-R in castrated eNOS
2/2 mice
demonstrate an increase in GSNO-R activity with castration in the
absence ofeNOS,suggestingthatandrogenshave aseparateeNOS-
independent mechanism by which they alter GSNO-R activity.
Thus, it is possible that the net effect in females in GSNO-R activity
is increased, in part, through S-nitrosylation by eNOS as well as by
the absence of what appears to be a distinct, androgen-dependent
effect.
In the pulmonary vascular bed, evidence has emerged for the
following paradigm: increased delivery of nitrosothiols to the
pulmonary vascular bed results in the activation of hypoxia related
gene regulatory proteins including specificity proteins and hypoxia
inducible factor-1 through S-nitrosylation reactions [11]. Down-
stream, this effect results in the upregulation of hypoxia-regulated
genes, leading to cellular and morphologic changes characteristic
of PH. Thus, excessive S-nitrosothiol delivery in the pulmonary
vasculature recapitulates hypoxia. To some extent, this paradigm
can provide insight into PH of diverse causes: 1) hypoxia results in
transnitrosation from deoxyhemoglobin to glutathione and other
thiols in the systemic periphery which then return in erythrocytes
and plasma and are dumped into the pulmonary vascular bed
Figure 6. Serum SNOAC levels are lower in female mice. Serum SNOAC was measured by mass spectrometry (MS) in C57BL6/129SvEv male
and female mice treated with NAC. Left panel = LC chromatogram: Right panel= MS spectrum. Serum from NAC-treated male (red) and female
(green) mice had a SNOAC peak (m/z 193) that co-migrated with the
15N-SNOAC standard (black). No signal was seen in non-treated mice (blue). The
amount of SNOAC was less in the female mice.
doi:10.1371/journal.pone.0014007.g006
Table 4. SNO/Hb levels are similar in untreated Male and
Female C57Bl6/129SvEv Mice.
Gender SNO/Hb
Male 7.75610
2562.49610
25
Female 8.75610
2561.50610
25
Left ventricular blood was collected from male (n=4) and female (n=4) mice
and subjected to reductive chemiluminescence in the presence of carbon
monoxide (3C assay). SNO values were normalized to hemoglobin content.
doi:10.1371/journal.pone.0014007.t004
Gender and GSNO-R Activity
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extent that normal levels of deoxygenation increase systemic
vascular S-nitrosothiols, a tripling of venous return in high flow
states triples the burden of S-nitrosothiols returning to the lung,
perhaps explaining high flow state-induced PH; 3) systemic
inflammation can increase erythrocytic S-nitrosothiol load,
contributing to the risk of PH seen in systemic inflammation.
Note the paradox: S-nitrosothiols delivered acutely to the
pulmonary vascular bed are vasodilators and will reverse PH;
whereas, chronic exposure of the pulmonary vascular bed to S-
nitrosothiols gradually causes pulmonary vascular remodeling and
chronic pulmonary hypertension. If increased GSNO-R activity in
female mice can protect against the adverse affects of nitrosative
stress associated with eNOS activation, chronic inflammation,
chronic hypoxemia and high flow states, why are female humans
at higher risk for the development of PH from a variety of causes
than are males? The answer may lie in GSNO-R itself. In the
absence of androgens and in the presence of eNOS activation,
increased GSNO-R activity is protective. However, this system
leaves females particularly vulnerable to GSNO-R dysfunction.
For example, if there is decreased GSNO-R activation by eNOS
or an androgen-mimetic effect to decrease GSNO-R activity in the
female pulmonary vascular endothelium, by virtue of increased
eNOS activity and the resulting chronic nitrosative stress, females
will be at increased risk for hypoxia-mimetic pulmonary vascular
remodeling. Indeed, there are single nucleotide polymorphisms
resulting in increased or decreased GSNO-R activity that appear
to be associated with both increased and decreased asthma risk
respectively [30]. These data suggest that future studies regarding
GSNO-R expression, genetics and activity in the lungs of women
with PH may be worthwhile.
In summary, GSNO-R activity is increased post-translationally
in the female murine lung. This observation is important because
Figure 7. Castration increases GSNO-R activity, protecting
against NAC-induced increases in right heart weight and
ventricular pressure. Male C57BL6/129SvEv mice with either intact
gonads or castrated were treated with (white bars) or without NAC
(black bars) for 3 weeks. (A) RVW and (B) RVP were measured. Castration
eliminated the increase in both RVW and RVP (N=11 intact, N=10
castrated, p,0.001).
doi:10.1371/journal.pone.0014007.g007
Figure 8. Castration increases GSNO-R S-nitrosylation and
activity. (A) Castrated mice show an increase in GSNO-R activity
compared to the male gonad intact animals. It should be noted that the
levels of GSNO-R activity seen in the castrated mice is similar to that
seen in the female mice. The data are presented as the amount of GSNO
remaining after 5 min as determined by LC/MS. (B) GSNO-R protein
expression in gonad intact and castrated animals was determined by
western blot. No differences in GSNO-R protein expression were seen in
the intact or castrated animals. (C) S-nitrosylated GSNO-R (SNO-GSNO-R)
was determined by biotin switch followed by western blot analysis
using anti-GSNO-R antibodies. S-nitrosylated GSNO-R levels were
elevated in the castrated animals.
doi:10.1371/journal.pone.0014007.g008
Figure 9. Androgen mediated increases in GSNO-R activity are
eNOS-independent. GSNO-R activity was measured in lung homog-
enates obtained from gonad intact and castrated eNOS
2/2 mice.
Castration resulted in a significant increase in GSNO-R activity as
measured by modified Saville Assay using 28 mM GSNO with no protein
precipitation. (n=6 intact, n=4 castrated, p,0.038).
doi:10.1371/journal.pone.0014007.g009
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stress associated with increased eNOS expression in female mice.
This may be particularly important in protecting against the high
flow state and chronic eNOS upregulation associated with
mammalian pregnancy [31,32]. In addition, it may also help to
explain why females, in general, are more tolerant of high altitude
living than males [33,34]. However, an extension of these murine
results to human studies has not yet been undertaken.
Materials and Methods
Materials
All chemical reagents used in the studies were obtained from
Sigma Chemical Company (St. Louis, MO) unless otherwise
stated.
Animals
All procedures in the treatment and care of the animals used in
this study were approved by the Animal Care and Use Committee
at the University of Virginia. Female C57BL6/129SvEv mice (10-
12 w) were exposed to normoxia, 52 mM N-acetyl cysteine, 1 mM
S-nitrosylated N-acetyl cysteine, or 10% oxygen for 3 weeks as
previously described [11]. Castrations were performed when
animals reached 3 w of age. All animals were anesthetized
using interperotineal injection of ketamine/xylazine (60–80/
5–10 mg/kg) prior to the procedure. In addition, the surgical site
was made aseptic using betadine solution and 70% ethyl alcohol.
Local anesthesia at the incision site was by infiltration of 0.1 ml
0.25% bipivicaine. For castration, a small incision was made at the
tip of the scrotum. The tunic opened and the testis, cauda
epidiymis, vas deferens and the spermatic blood vessels exterior-
ized. The blood vessels and the vas deferens were cauterized
and the testis and epididymis removed. The remaining tissue
was returned into the sac and the procedure repeated for the
other testis. The skin incision was closed with Nexaband. Mice are
kept warm after surgery until they are responsive to stimuli
and monitored until they can completely right themselves on
their own. Right ventricular pressure was measured in anesthe-
tized mice using a 1.4 F Millar catheter/transducer as previous-
ly described [11]. Right heart hypertrophy was measured as a
ratio of the weight of the right ventricle/weight of the left ventricle
+ septum.
Measurement of S-nitrosoglutathione reductase activity
LC/MS: Lung homogenate (0.25–0.5 mg) in homogenation
buffer was incubated with GSNO (28 mM) and 2 mM GSH in the
presence or absence of 300 mM NADH at 37uC for 5 minutes.
Protein was precipitated from the reaction using 8% tricholor-
acetic acid. HPLC analysis was performed on a Waters 2695
separation module using a Waters Symmetry C8 (2.16150 mm)
column. GSNO analytes were eluted using an isocratic method of
95% formic acid (0.1%) in water and 5% methanol. Mass
spectroscopy was performed using a Finnigan LCQ ion trap mass
spectrometer equipped with an electrospray ionization source.
Data were collected in positive ion mode with selective ion
monitoring at m/z=336.5–337.5 and quantified against GS
15NO
cations m/z=337.5–338.5. Integrated peak areas were deter-
mined using Xcalibur software. GSNO-dependent NADH
Consumption [35]: Cell lysate (0.3 ug/ml) was incubated with
75 mM NADH in reaction buffer (20 mM Tris HCL pH 8.0 and
0.5 mM EDTA containing 0 or 100 mM GSNO at room
temperature. NADH fluorescence (absorption at 340 nm and
emission at 455 mm) was measured over time in a FLUOstar
Omega (BMG Labtech, Offenburg, Germany). Concentration of
NADH was determined from a standard curve. Modified Saville
Assay: GSNO-R activity was measured by modified Saville Assay.
Briefly, 250 mg of cell lysate or lung homogenate was incubated in
the absence or presence of 300 mM NADH, in the presence of
2 mM GSH and 28 mM or 100 mM GSNO. Assay was performed
with and without protein precipitation (Table 3). Two aliquots of
75 ml were placed into a 96 well plate at 1 min intervals for a total
of 5 min. One aliquot was placed with 75 mlo f( +) reagent (58 mM
Sulfanilamide +7.36 mM HgCl2 in 1 N HCl) while the second
aliquot was placed with (2) reagent (58 mM Sulfanilamide in 1 N
HCl). Samples were incubated 5 min in the dark. At the end of
this incubation, 75 ml of (N) reagent (0.77 M n-(1-napthyl)
ethylene-diamine dihydrochloride) was added. Samples were
incubated 5–10 min for color to develop. Absorbance was read
at 540 nm. Amount of GSNO remaining in the reaction was
determined from a GSNO standard curve. Activity was obtained
from the slope of the time course divided by the amount of protein
in the reaction.
Measurement of S-nitroso-N-acetyl cysteine (SNOAC)
The abundance of SNOAC was determined by liquid
chromatography/mass spectroscopy as previously described [11].
Immunoprecipitation
Cell lysate or lung homogenate (100–300 mg) prepared in lysis
buffer (20 mM Tris pH 7.6, 150 mM NaCl, 2 mM EDTA,
10%glycerol 1%Triton X-100 +1X proteinase inhibiters) were
immunoprecipitated using 4 mg anti-eNOS antibody (BD Biosci-
ences, San Diego) overnight at 4uC on a rotator. Samples were
incubated with 100 ml protein A agarose beads (Roche Diagnos-
tics, Mannheim, Germany) for 2–4 hours at 4uC. At the end of the
incubation, the agarose beads were spun at 30006g for 1 min and
washed three times with lysis buffer. Protein was eluted from the
protein A agarose beads by incubation with 50 ml SDS loading
buffer.
Biotin-Switch
The biotin switch procedure for the identification of S-
nitrosothiols was performed to identify S-nitrosylated proteins
[36]. Briefly, cell lysate or lung homogenate (100–300 mg) were
precipitated using acetone and resuspended in 100 ml HEN Buffer
(250 mM HEPES pH 7.7, 1 mM EDTA, 0.1 mM neocuproine).
Samples were mixed with 4 volumes Blocking Buffer (9 vol
HEN+1 vol 25%SDS containing 20 mM MMTS) and incubated
at 50uC for 20 min with shaking. Protein was precipitated by
acetone, resuspended in HEN Buffer containing 1 mM Biotin-
HPDP (Pierce) and 1 mM ascorbate and incubated for 1 h at
room temperature. Biotin HPDP was removed by precipitation
with acetone and pellet resuspended in 100 ml HEN buffer.
Resuspended sample was neutralized using Neutralization Buffer
(20 mM HEPES pH 7.7, 10 mm NaCl, 1 mM EDTA, 0.5%
Triton X-100.) Biotinylated proteins were isolated by incubation
with Streptavidin agarose for 1 h at room temperature. Resin was
washed 5 times with Neutralization Buffer containing 600 mM
NaCl and biotinylated protein eluted with 50 ml 2X SDS PAGE
Loading Buffer.
Western Blot analysis
Proteins were separated on a 10% polyacrylamide gel as
previously described [11]. Proteins were transferred to Immobilon-
P transfer membranes (Billerica, MA) and signal detected using
SuperSignal West Pico Chemiluminescent Substrate (Thermo
Scientific, Rockford, IL).
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All data will be expressed as the mean 6 SEM. All statistical
analysis was performed using Sigma Stat software. Data
comparing 2 groups were analyzed using a paired T test, with
p,0.05 considered significant. Data comparing more than one
group will be analyzed by one way ANOVA. Significance was
determined using the Holm Sidak post hoc test with p,0.05
considered significant.
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